{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:58:30Z","timestamp":1776275910729,"version":"3.50.1"},"reference-count":61,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The liver plays a critical role in maintaining ammonia homeostasis. Urea cycle defects, liver injury, or failure and glutamine synthetase (GS) deficiency result in hyperammonemia, serious clinical conditions, and lethality. In this study we used a mouse model with a defect in the urea cycle enzyme ornithine transcarbamylase (Otcspf-ash) to test the hypothesis that glucagon receptor inhibition using a monoclonal blocking antibody will reduce the hyperammonemia and associated lethality induced by a high-protein diet, which exacerbates disease. We found reduced expression of glutaminase, which degrades glutamine and increased expression of GS in livers of Otcspf-ash mice treated with the glucagon receptor blocking antibody. The gene expression changes favor ammonia consumption and were accompanied by increased circulating glutamine levels and diminished hyperammonemia. Otcspf-ash mice treated with the glucagon receptor-blocking antibody gained lean and body mass and had increased survival. These data suggest that glucagon receptor inhibition using a monoclonal antibody could reduce the risk for hyperammonemia and other clinical manifestations of patients suffering from defects in the urea cycle, liver injury, or failure and GS deficiency.<\/jats:p>","DOI":"10.1210\/endocr\/bqaa211","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T14:54:43Z","timestamp":1605711283000},"source":"Crossref","is-referenced-by-count":6,"title":["Glucagon Receptor Inhibition Reduces Hyperammonemia and Lethality in Male Mice with Urea Cycle Disorder"],"prefix":"10.1210","volume":"162","author":[{"given":"Katie","family":"Cavino","sequence":"first","affiliation":[{"name":"Regeneron Pharmaceuticals, Tarrytown, New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biin","family":"Sung","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Tarrytown, New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Su","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Tarrytown, New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erqian","family":"Na","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Tarrytown, New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinrang","family":"Kim","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Tarrytown, New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiping","family":"Cheng","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Tarrytown, New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Gromada","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Tarrytown, New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6121-9589","authenticated-orcid":false,"given":"Haruka","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Tarrytown, New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"issue":"11","key":"2021121701452598900_CIT0001","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3390\/nu10111564","article-title":"Glutamine: metabolism and immune function, supplementation and clinical translation","volume":"10","author":"Cruzat","year":"2018","journal-title":"Nutrients"},{"issue":"4","key":"2021121701452598900_CIT0002","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jpeds.2013.12.024","article-title":"Significant hepatic involvement in patients with ornithine transcarbamylase deficiency","volume":"164","author":"Gallagher","year":"2014","journal-title":"J Pediatr."},{"issue":"6","key":"2021121701452598900_CIT0003","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10545-007-0709-5","article-title":"Neurological implications of urea cycle disorders","volume":"30","author":"Gropman","year":"2007","journal-title":"J Inherit Metab Dis."},{"issue":"10 Suppl","key":"2021121701452598900_CIT0004","doi-asserted-by":"crossref","first-page":"2775S","DOI":"10.1093\/jn\/134.10.2775S","article-title":"Clinical consequences of urea cycle enzyme deficiencies and potential links to arginine and nitric oxide metabolism","volume":"134","author":"Scaglia","year":"2004","journal-title":"J Nutr."},{"issue":"3","key":"2021121701452598900_CIT0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ymgme.2013.01.006","article-title":"Histopathological findings in livers of patients with urea cycle disorders","volume":"108","author":"Yaplito-Lee","year":"2013","journal-title":"Mol Genet Metab."},{"issue":"1","key":"2021121701452598900_CIT0006","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hep.28852","article-title":"Pivotal role of glutamine synthetase in ammonia detoxification","volume":"65","author":"Hakvoort","year":"2017","journal-title":"Hepatology."},{"key":"2021121701452598900_CIT0007","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2741\/2070","article-title":"Glutamine metabolism and signaling in the liver","volume":"12","author":"H\u00e4ussinger","year":"2007","journal-title":"Front Biosci."},{"issue":"4S Suppl","key":"2021121701452598900_CIT0008","doi-asserted-by":"crossref","first-page":"983S","DOI":"10.1093\/jn\/130.4.983S","article-title":"Glutamine and glutamate metabolism across the liver sinusoid","volume":"130","author":"Watford","year":"2000","journal-title":"J Nutr."},{"issue":"4","key":"2021121701452598900_CIT0009","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1378\/chest.06-2940","article-title":"Hyperammonemia in the ICU","volume":"132","author":"Clay","year":"2007","journal-title":"Chest."},{"issue":"4 Suppl","key":"2021121701452598900_CIT0010","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.ccc.2005.05.007","article-title":"Urea cycle disorders: clinical presentation outside the newborn period","volume":"21","author":"Smith","year":"2005","journal-title":"Crit Care Clin."},{"key":"2021121701452598900_CIT0011","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.acc.2014.09.002","article-title":"Ammonia metabolism and hyperammonemic disorders","volume":"67","author":"Walker","year":"2014","journal-title":"Adv Clin Chem."},{"key":"2021121701452598900_CIT0012","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-015-0266-1","article-title":"Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients","volume":"10","author":"Brassier","year":"2015","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"2021121701452598900_CIT0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM197301042880101","article-title":"Ornithine transcarbamylase deficiency: a cause of lethal neonatal hyperammonemia in males","volume":"288","author":"Campbell","year":"1973","journal-title":"N Engl J Med."},{"issue":"1","key":"2021121701452598900_CIT0014","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13023-016-0493-0","article-title":"Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013","volume":"11","author":"Unsinn","year":"2016","journal-title":"Orphanet J Rare Dis."},{"issue":"2","key":"2021121701452598900_CIT0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00467-011-1838-5","article-title":"Hyperammonemia in review: pathophysiology, diagnosis, and treatment","volume":"27","author":"Auron","year":"2012","journal-title":"Pediatr Nephrol."},{"key":"2021121701452598900_CIT0016","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1172-7-32","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders","volume":"7","author":"H\u00e4berle","year":"2012","journal-title":"Orphanet J Rare Dis."},{"issue":"2","key":"2021121701452598900_CIT0017","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/21678707.2017.1405807","article-title":"Glycerol phenylbutyrate for the maintenance treatment of patients with deficiencies in enzymes of the urea cycle","volume":"5","author":"Longo","year":"2017","journal-title":"Expert Opin Orphan Drugs"},{"issue":"3","key":"2021121701452598900_CIT0018","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI109717","article-title":"Glucagon deficiency and hyperaminoacidemia after total pancreatectomy","volume":"65","author":"Boden","year":"1980","journal-title":"J Clin Invest."},{"issue":"5","key":"2021121701452598900_CIT0019","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1172\/JCI109381","article-title":"Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients","volume":"63","author":"Muller","year":"1979","journal-title":"J Clin Invest."},{"issue":"6","key":"2021121701452598900_CIT0020","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.cmet.2017.05.011","article-title":"Interrupted glucagon signaling reveals hepatic \u03b1 cell axis and role for L-glutamine in \u03b1 cell proliferation","volume":"25","author":"Dean","year":"2017","journal-title":"Cell Metab."},{"issue":"1","key":"2021121701452598900_CIT0021","doi-asserted-by":"crossref","first-page":"E93","DOI":"10.1152\/ajpendo.00198.2017","article-title":"Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis","volume":"314","author":"Galsgaard","year":"2018","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"6","key":"2021121701452598900_CIT0022","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.cmet.2017.05.006","article-title":"Amino acid transporter Slc38a5 controls glucagon receptor inhibition-induced pancreatic \u03b1 cell hyperplasia in mice","volume":"25","author":"Kim","year":"2017","journal-title":"Cell Metab."},{"issue":"8","key":"2021121701452598900_CIT0023","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1210\/en.2015-1011","article-title":"Glucagon receptor blockade with a human antibody normalizes blood glucose in diabetic mice and monkeys","volume":"156","author":"Okamoto","year":"2015","journal-title":"Endocrinology."},{"issue":"3","key":"2021121701452598900_CIT0024","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.celrep.2015.06.034","article-title":"Glucagon couples hepatic amino acid catabolism to mTOR-dependent regulation of \u03b1-cell mass","volume":"12","author":"Solloway","year":"2015","journal-title":"Cell Rep."},{"issue":"1","key":"2021121701452598900_CIT0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2337\/db11-0739","article-title":"Remodeling of hepatic metabolism and hyperaminoacidemia in mice deficient in proglucagon-derived peptides","volume":"61","author":"Watanabe","year":"2012","journal-title":"Diabetes."},{"issue":"17","key":"2021121701452598900_CIT0026","doi-asserted-by":"crossref","first-page":"E4111","DOI":"10.1073\/pnas.1721403115","article-title":"Glucagon contributes to liver zonation","volume":"115","author":"Cheng","year":"2018","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"2021121701452598900_CIT0027","doi-asserted-by":"crossref","first-page":"e0122966","DOI":"10.1371\/journal.pone.0122966","article-title":"Functional characterization of the spf\/ash splicing variation in OTC deficiency of mice and man","volume":"10","author":"Rivera-Barahona","year":"2015","journal-title":"Plos One."},{"issue":"3","key":"2021121701452598900_CIT0028","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nbt.3469","article-title":"A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice","volume":"34","author":"Yang","year":"2016","journal-title":"Nat Biotechnol."},{"key":"2021121701452598900_CIT0029","volume-title":"RRID:AB_2783540"},{"key":"2021121701452598900_CIT0030","volume-title":"RRID:AB_2783872"},{"key":"2021121701452598900_CIT0031","volume-title":"RRID:AB_2783839"},{"key":"2021121701452598900_CIT0032","volume-title":"RRID:AB_397880"},{"key":"2021121701452598900_CIT0033","volume-title":"RRID:AB_11031431"},{"key":"2021121701452598900_CIT0034","volume-title":"RRID:AB_2876368"},{"key":"2021121701452598900_CIT0035","volume-title":"RRID:AB_561053"},{"key":"2021121701452598900_CIT0036","volume-title":"RRID:AB_2340393"},{"key":"2021121701452598900_CIT0037","volume-title":"RRID:AB_2340390"},{"key":"2021121701452598900_CIT0038","volume-title":"RRID:AB_2307391"},{"key":"2021121701452598900_CIT0039","volume-title":"RRID:AB_10015289"},{"key":"2021121701452598900_CIT0040","volume-title":"RRID:AB_2783539"},{"key":"2021121701452598900_CIT0041","volume-title":"RRID:AB_2617169"},{"issue":"7","key":"2021121701452598900_CIT0042","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1074\/jbc.271.7.3639","article-title":"Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors","volume":"271","author":"Ye","year":"1996","journal-title":"J Biol Chem."},{"issue":"3","key":"2021121701452598900_CIT0043","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/oxfordjournals.jhered.a108500","article-title":"A new allele of the sparse fur gene in the mouse","volume":"65","author":"Doolittle","year":"1974","journal-title":"J Hered."},{"issue":"2","key":"2021121701452598900_CIT0044","first-page":"205","article-title":"Acute metabolic decompensation due to influenza in a mouse model of ornithine transcarbamylase deficiency","volume":"7","author":"McGuire","year":"2014","journal-title":"Dis Model Mech."},{"key":"2021121701452598900_CIT0045","author":"Cavino"},{"issue":"2","key":"2021121701452598900_CIT0046","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11011-013-9377-3","article-title":"Branched-chain amino acids and muscle ammonia detoxification in cirrhosis","volume":"28","author":"Dam","year":"2013","journal-title":"Metab Brain Dis."},{"issue":"3","key":"2021121701452598900_CIT0047","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3350\/cmh.2019.0015","article-title":"Sarcopenia: ammonia metabolism and hepatic encephalopathy","volume":"25","author":"Jindal","year":"2019","journal-title":"Clin Mol Hepatol."},{"issue":"45","key":"2021121701452598900_CIT0048","doi-asserted-by":"crossref","first-page":"18162","DOI":"10.1073\/pnas.1317049110","article-title":"Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-\u03baB-mediated mechanism","volume":"110","author":"Qiu","year":"2013","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"8","key":"2021121701452598900_CIT0049","doi-asserted-by":"crossref","first-page":"E983","DOI":"10.1152\/ajpendo.00183.2012","article-title":"Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis","volume":"303","author":"Qiu","year":"2012","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"24","key":"2021121701452598900_CIT0050","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.1113\/JP272796","article-title":"Hyperammonaemia-induced skeletal muscle mitochondrial dysfunction results in cataplerosis and oxidative stress","volume":"594","author":"Davuluri","year":"2016","journal-title":"J Physiol."},{"issue":"6","key":"2021121701452598900_CIT0051","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1046\/j.1523-1755.1998.00952.x","article-title":"Mesangial cell hypertrophy induced by NH4Cl: role of depressed activities of cathepsins due to elevated lysosomal pH","volume":"53","author":"Ling","year":"1998","journal-title":"Kidney Int."},{"issue":"5968","key":"2021121701452598900_CIT0052","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.1179689","article-title":"Regulation of cellular metabolism by protein lysine acetylation","volume":"327","author":"Zhao","year":"2010","journal-title":"Science."},{"issue":"20","key":"2021121701452598900_CIT0053","doi-asserted-by":"crossref","first-page":"13669","DOI":"10.1074\/jbc.M901921200","article-title":"Lysine 88 acetylation negatively regulates ornithine carbamoyltransferase activity in response to nutrient signals","volume":"284","author":"Yu","year":"2009","journal-title":"J Biol Chem."},{"issue":"13","key":"2021121701452598900_CIT0054","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.3390\/ijms20133314","article-title":"Glucagon receptor signaling and glucagon resistance","volume":"20","author":"Janah","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"22","key":"2021121701452598900_CIT0055","doi-asserted-by":"crossref","first-page":"16167","DOI":"10.1074\/jbc.M113.460246","article-title":"cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 2 (CRTC2) promotes glucagon clearance and hepatic amino acid catabolism to regulate glucose homeostasis","volume":"288","author":"Erion","year":"2013","journal-title":"J Biol Chem."},{"issue":"3","key":"2021121701452598900_CIT0056","doi-asserted-by":"crossref","first-page":"857S","DOI":"10.3945\/ajcn.2009.27462Z","article-title":"Hepatic glutamate metabolism: a tale of 2 hepatocytes","volume":"90","author":"Brosnan","year":"2009","journal-title":"Am J Clin Nutr."},{"key":"2021121701452598900_CIT0057","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0065-2571(86)90013-0","article-title":"Regulation of hepatic ammonia metabolism: the intercellular glutamine cycle","volume":"25","author":"H\u00e4ussinger","year":"1986","journal-title":"Adv Enzyme Regul."},{"issue":"1-3","key":"2021121701452598900_CIT0058","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000468779","article-title":"Hepatocyte heterogeneity in the metabolism of amino acids and ammonia","volume":"46","author":"H\u00e4ussinger","year":"1992","journal-title":"Enzyme."},{"issue":"1","key":"2021121701452598900_CIT0059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1987.tb10728.x","article-title":"Urea synthesis from ammonia in periportal and pericentral regions of the liver lobule. Effect of oxygen","volume":"163","author":"Kari","year":"1987","journal-title":"Eur J Biochem."},{"issue":"3","key":"2021121701452598900_CIT0060","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00125-017-4535-5","article-title":"Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids","volume":"61","author":"Wewer Albrechtsen","year":"2018","journal-title":"Diabetologia."},{"issue":"1","key":"2021121701452598900_CIT0061","doi-asserted-by":"crossref","first-page":"G91","DOI":"10.1152\/ajpgi.00216.2017","article-title":"Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes","volume":"314","author":"Wewer Albrechtsen","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol."}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqaa211\/34382962\/bqaa211.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/162\/1\/bqaa211\/41790702\/bqaa211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/162\/1\/bqaa211\/41790702\/bqaa211.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T01:46:11Z","timestamp":1639705571000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqaa211\/5988952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqaa211","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1]]},"published":{"date-parts":[[2020,11,18]]},"article-number":"bqaa211"}}